良性前列腺增生与慢性前列腺炎发病特点的相关性分析

目的 探讨良性前列腺增生(BPH)与慢性前列腺炎(CP)发病特点的相关性. 方法 BPH患者300例.平均年龄72(51～96)岁.根据直肠指诊及B超检查结果分为Ⅰ、Ⅱ、Ⅲ度增生3组,分别为85、139和76例.对每组合并CP的发生率及不同方法 治疗效果进行统计学分析.结果 300例患者中合并CP者233例(77.7%),其中Ⅰ、Ⅱ、Ⅲ度增生组合并CP者分别为53例(62.6%)、113例(81.3%)、67例(88.2%),3组患者合并CP的发生率差异有统计学意义(P<0.05).合并CP患者分为2组,均给予抗前列腺增生药物治疗,其中一组同时服环丙沙星及消炎痛栓纳肛,比较各组患者治疗前后国际前列腺症状评分(IPSS)、生活质量评分(QOL)变化差异.Ⅰ、Ⅱ度增生组合并CP的患者加用抗感染治疗前后IPSS(7.5±0.6与5.5±0.9、11.5±1.5与10.0±0.5)、QOL评分(4.1±1.0与3.0±0.5、4.8±1.1与3.2±0.4)差异有统计学意义(P<0.01),Ⅲ度增生组合并CP者加用抗感染治疗前后(IPSS 27.8±2.8与25.0±2.5,QOL评分5.5±0.4与4.5±1.0)差异无统计学意义(P>0.05). 结论 BPH患者常合并CP,腺体增生程度与CP发生率呈正相关,合并CP的Ⅰ、Ⅱ度增生患者抗炎治疗效果好于Ⅲ度增生合并CP患者.

Relationship between benign prostatic hyperplasia and chronic prostatitis

Objective To investigate the relationship between benign prostatic hyperplasia (BPH) andchronic prostatitis(CP). Methods Three hundred BPH patients were studied, aged from 51 to 96 (aver-age 72). All patients were divided into 3 groups (Ⅰ°、Ⅱ°and Ⅲ°)according to result of digital rectal examina-tion, which include 85 cases , 139 cases and 76 cases respectively. The incidence of CP among 3 groups were compared and analyzed. Results Two hundreds and thirty-five of the 300 cases with BPH were accompa-nied with CP(77.7%). Among the 233 cases, 53 cases were in Ⅰ degree BPH group (53 / 85, 62.4% ), 113 cases were in Ⅱ degree BPH group (113/139, 81.3%), 67 cases were in Ⅲ degree BPH group (67/76, 88.2%). Conclusions Many BPH patients were accompanied by CP. The prostate size and the inflamma-tion of prostate were positive correlated. The effect of anti-inflammatory treatment in Ⅰ degree and Ⅱ degreeBPH patients was better than Ⅲ degree BPH patients.